587 related articles for article (PubMed ID: 27287095)
1. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.
Jiao J; Li X; Zhang S; Liu J; Di D; Zhang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():26-33. PubMed ID: 27287095
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging.
Zhao Q; Wang S; Yang Y; Li X; Di D; Zhang C; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():475-484. PubMed ID: 28576012
[TBL] [Abstract][Full Text] [Related]
3. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
4. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
[TBL] [Abstract][Full Text] [Related]
5. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
[TBL] [Abstract][Full Text] [Related]
6. pH and redox dual response nano-suppository for the treatment of ulcerative colitis.
Wu Y; Song J; Wang X; Li L; Chang J; Ma Y
Drug Deliv Transl Res; 2024 Jul; 14(7):1954-1968. PubMed ID: 38191781
[TBL] [Abstract][Full Text] [Related]
7. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
8. Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: Preparation, sustained release, cellular uptake and pharmacokinetics.
Qiu Y; Wu C; Jiang J; Hao Y; Zhao Y; Xu J; Yu T; Ji P
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():835-843. PubMed ID: 27987779
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
10. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
[TBL] [Abstract][Full Text] [Related]
11. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
12. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S
ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of doxorubicin-PLGA loaded chitosan stabilized (Mn, Zn)Fe2O4 nanoparticles: Biological activity and pH-responsive drug release.
Montha W; Maneeprakorn W; Buatong N; Tang IM; Pon-On W
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():235-240. PubMed ID: 26652369
[TBL] [Abstract][Full Text] [Related]
14. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
Teng X; Cheng S; Meng R; Zheng S; Yang L; Ma Q; Jiang W; He J
J Nanosci Nanotechnol; 2015 May; 15(5):3773-9. PubMed ID: 26505004
[TBL] [Abstract][Full Text] [Related]
15. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
16. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
[TBL] [Abstract][Full Text] [Related]
17. PEGylated mesoporous silica as a redox-responsive drug delivery system for loading thiol-containing drugs.
Zhao Q; Wang C; Liu Y; Wang J; Gao Y; Zhang X; Jiang T; Wang S
Int J Pharm; 2014 Dec; 477(1-2):613-22. PubMed ID: 25445534
[TBL] [Abstract][Full Text] [Related]
18. Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release.
Hakeem A; Zahid F; Duan R; Asif M; Zhang T; Zhang Z; Cheng Y; Lou X; Xia F
Nanoscale; 2016 Mar; 8(9):5089-97. PubMed ID: 26868866
[TBL] [Abstract][Full Text] [Related]
19. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
Li J; Du X; Zheng N; Xu L; Xu J; Li S
Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
[TBL] [Abstract][Full Text] [Related]
20. pH/GSH-Dual-Sensitive Hollow Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Cancer Therapy.
Chen Z; Wan L; Yuan Y; Kuang Y; Xu X; Liao T; Liu J; Xu ZQ; Jiang B; Li C
ACS Biomater Sci Eng; 2020 Jun; 6(6):3375-3387. PubMed ID: 33463161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
